17 November 2020
AfriAg Global
PLC
(‘AfriAg’ or the
‘Company’)
Apollon’s
Stephen Barnhill at Prohibition
Partners Live
AfriAg Global PLC (London AQSE: AFRI) is pleased to announce
that Dr. Stephen Barnhill, Chairman
of AfriAg’s RTO target, Apollon Formularies Ltd., will be speaking
at 12:30 pm today at Prohibition
Partners LIVE, the leading virtual cannabis conference.
Dr. Barnhill will be speaking as part of a panel, discussing the
question ‘Is Personalised Medicine the Future of Cannabis?’,
alongside industry leaders; Adrian
Fischer, Managing Director of DEMECAN, Pat McCutcheon, CEO and Chairman of MediPharma
Labs and David Babcock, CEO of Drug
Science, as moderator.
Tickets to attend the conference can be found through the link
below:
https://prohibitionpartners.live/tickets/
-ENDS-
For further information on AfriAg Global please visit
the www.afriagglobal.com or please contact;
AfriAg Global
Plc:
David Lenigas (Executive Chairman)
+44 (0) 78821 825378
Peterhouse Capital
Limited
+44 (0) 20 7469 0930
Guy Miller
About Prohibition Partners LIVE:
Prohibition Partners LIVE is the leading virtual cannabis
conference, connecting you to the international cannabis industry
from anywhere in the world. This November
17th - 20th, Prohibition Partners LIVE is bringing together
the global cannabis and psychedelics community for a virtual
week
